Why is Ishita Drugs falling/rising?

As of 02-Jul, Ishita Drugs & Industries Ltd is experiencing a price increase, with the current price at Rs 83.93, reflecting a change of Rs 2.33 or 2.86%. The stock has outperformed its sector by 2.78% today, reaching an intraday high of Rs 84.01. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. However, there has been a significant drop in investor participation, with delivery volume on 01-Jul falling by 93.03% compared to the 5-day average. Despite this decline in participation, the stock has shown strong performance over various periods, including a 1-month return of 11.91% and a 1-year return of 22.78%.
In the broader market context, Ishita Drugs has outperformed the Sensex, which has only increased by 0.79% over the past week while Ishita Drugs rose by 3.23%. This trend continues in the 1-month comparison, where the stock's return of 11.91% significantly exceeds the Sensex's 2.50%. Despite the stock's year-to-date performance being negative at -9.20% compared to the Sensex's positive 6.75%, the long-term performance remains strong, with a 3-year return of 80.88% against the Sensex's 57.65%. Overall, the combination of short-term gains and strong historical performance suggests that the stock's recent rise is supported by its relative strength compared to the broader market, despite the noted decline in investor participation.